nodes	percent_of_prediction	percent_of_DWPC	metapath
Bimatoprost—PTGER3—connective tissue—systemic scleroderma	0.015	0.155	CbGeAlD
Bimatoprost—PTGER3—smooth muscle tissue—systemic scleroderma	0.0137	0.142	CbGeAlD
Bimatoprost—PTGFR—smooth muscle tissue—systemic scleroderma	0.0109	0.114	CbGeAlD
Bimatoprost—PTGER3—digestive system—systemic scleroderma	0.0108	0.112	CbGeAlD
Bimatoprost—PTGER3—lung—systemic scleroderma	0.00902	0.0937	CbGeAlD
Bimatoprost—AKR1C3—smooth muscle tissue—systemic scleroderma	0.00889	0.0923	CbGeAlD
Bimatoprost—PTGFR—tendon—systemic scleroderma	0.00822	0.0854	CbGeAlD
Bimatoprost—PTGFR—lung—systemic scleroderma	0.00721	0.0749	CbGeAlD
Bimatoprost—AKR1C3—tendon—systemic scleroderma	0.00668	0.0694	CbGeAlD
Bimatoprost—AKR1C3—lung—systemic scleroderma	0.00586	0.0609	CbGeAlD
Bimatoprost—Bronchitis—Lisinopril—systemic scleroderma	0.00283	0.00313	CcSEcCtD
Bimatoprost—Insomnia—Pentoxifylline—systemic scleroderma	0.00282	0.00312	CcSEcCtD
Bimatoprost—Nervousness—Captopril—systemic scleroderma	0.00281	0.00311	CcSEcCtD
Bimatoprost—Chest pain—Mometasone—systemic scleroderma	0.0028	0.0031	CcSEcCtD
Bimatoprost—Dyspnoea—Pentoxifylline—systemic scleroderma	0.00278	0.00307	CcSEcCtD
Bimatoprost—Somnolence—Pentoxifylline—systemic scleroderma	0.00277	0.00306	CcSEcCtD
Bimatoprost—Liver function test abnormal—Mycophenolate mofetil—systemic scleroderma	0.00275	0.00304	CcSEcCtD
Bimatoprost—Rhinitis—Leflunomide—systemic scleroderma	0.00274	0.00304	CcSEcCtD
Bimatoprost—Dry mouth—Mometasone—systemic scleroderma	0.00274	0.00303	CcSEcCtD
Bimatoprost—Dyspepsia—Pentoxifylline—systemic scleroderma	0.00274	0.00303	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Lisinopril—systemic scleroderma	0.00273	0.00302	CcSEcCtD
Bimatoprost—Sinusitis—Mycophenolic acid—systemic scleroderma	0.00273	0.00302	CcSEcCtD
Bimatoprost—Vision blurred—Captopril—systemic scleroderma	0.00273	0.00302	CcSEcCtD
Bimatoprost—Pharyngitis—Leflunomide—systemic scleroderma	0.00272	0.00301	CcSEcCtD
Bimatoprost—Oedema peripheral—Leflunomide—systemic scleroderma	0.0027	0.00298	CcSEcCtD
Bimatoprost—Connective tissue disorder—Leflunomide—systemic scleroderma	0.00269	0.00298	CcSEcCtD
Bimatoprost—Infection—Mometasone—systemic scleroderma	0.00267	0.00295	CcSEcCtD
Bimatoprost—Rhinitis—Mycophenolic acid—systemic scleroderma	0.00262	0.0029	CcSEcCtD
Bimatoprost—Depression—Lisinopril—systemic scleroderma	0.00261	0.00289	CcSEcCtD
Bimatoprost—Mediastinal disorder—Azathioprine—systemic scleroderma	0.00261	0.00289	CcSEcCtD
Bimatoprost—Pharyngitis—Mycophenolic acid—systemic scleroderma	0.00259	0.00287	CcSEcCtD
Bimatoprost—Asthma—Mycophenolate mofetil—systemic scleroderma	0.00258	0.00285	CcSEcCtD
Bimatoprost—Skin discolouration—Methotrexate—systemic scleroderma	0.00257	0.00285	CcSEcCtD
Bimatoprost—Oedema peripheral—Mycophenolic acid—systemic scleroderma	0.00257	0.00285	CcSEcCtD
Bimatoprost—Connective tissue disorder—Mycophenolic acid—systemic scleroderma	0.00257	0.00284	CcSEcCtD
Bimatoprost—Eye disorder—Leflunomide—systemic scleroderma	0.00256	0.00283	CcSEcCtD
Bimatoprost—Palpitations—Captopril—systemic scleroderma	0.00256	0.00283	CcSEcCtD
Bimatoprost—Cough—Captopril—systemic scleroderma	0.00252	0.00279	CcSEcCtD
Bimatoprost—Visual impairment—Mycophenolic acid—systemic scleroderma	0.00252	0.00278	CcSEcCtD
Bimatoprost—Bronchitis—Mycophenolate mofetil—systemic scleroderma	0.00248	0.00274	CcSEcCtD
Bimatoprost—Mediastinal disorder—Leflunomide—systemic scleroderma	0.00247	0.00273	CcSEcCtD
Bimatoprost—Chest pain—Captopril—systemic scleroderma	0.00246	0.00272	CcSEcCtD
Bimatoprost—Sinusitis—Lisinopril—systemic scleroderma	0.00246	0.00272	CcSEcCtD
Bimatoprost—Eye disorder—Mycophenolic acid—systemic scleroderma	0.00244	0.0027	CcSEcCtD
Bimatoprost—Dry mouth—Captopril—systemic scleroderma	0.00241	0.00266	CcSEcCtD
Bimatoprost—Inflammation—Methotrexate—systemic scleroderma	0.0024	0.00265	CcSEcCtD
Bimatoprost—Dyspnoea—Mometasone—systemic scleroderma	0.0024	0.00265	CcSEcCtD
Bimatoprost—Angiopathy—Mycophenolic acid—systemic scleroderma	0.00237	0.00262	CcSEcCtD
Bimatoprost—Dyspepsia—Mometasone—systemic scleroderma	0.00237	0.00262	CcSEcCtD
Bimatoprost—Rhinitis—Lisinopril—systemic scleroderma	0.00236	0.00261	CcSEcCtD
Bimatoprost—Mediastinal disorder—Mycophenolic acid—systemic scleroderma	0.00235	0.0026	CcSEcCtD
Bimatoprost—Pharyngitis—Lisinopril—systemic scleroderma	0.00233	0.00258	CcSEcCtD
Bimatoprost—Oedema peripheral—Lisinopril—systemic scleroderma	0.00232	0.00256	CcSEcCtD
Bimatoprost—Pain—Mometasone—systemic scleroderma	0.0023	0.00254	CcSEcCtD
Bimatoprost—Depression—Mycophenolate mofetil—systemic scleroderma	0.00229	0.00253	CcSEcCtD
Bimatoprost—Cystitis noninfective—Methotrexate—systemic scleroderma	0.00227	0.00251	CcSEcCtD
Bimatoprost—Vision blurred—Leflunomide—systemic scleroderma	0.00225	0.00249	CcSEcCtD
Bimatoprost—Cystitis—Methotrexate—systemic scleroderma	0.00225	0.00248	CcSEcCtD
Bimatoprost—Asthenia—Pentoxifylline—systemic scleroderma	0.00223	0.00247	CcSEcCtD
Bimatoprost—Tension—Mycophenolic acid—systemic scleroderma	0.00223	0.00247	CcSEcCtD
Bimatoprost—Nervousness—Mycophenolic acid—systemic scleroderma	0.00221	0.00244	CcSEcCtD
Bimatoprost—Pruritus—Pentoxifylline—systemic scleroderma	0.0022	0.00244	CcSEcCtD
Bimatoprost—Sinusitis—Mycophenolate mofetil—systemic scleroderma	0.00215	0.00238	CcSEcCtD
Bimatoprost—Vision blurred—Mycophenolic acid—systemic scleroderma	0.00214	0.00237	CcSEcCtD
Bimatoprost—Vertigo—Leflunomide—systemic scleroderma	0.00214	0.00237	CcSEcCtD
Bimatoprost—Insomnia—Captopril—systemic scleroderma	0.00213	0.00236	CcSEcCtD
Bimatoprost—Angiopathy—Lisinopril—systemic scleroderma	0.00213	0.00236	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	0.00213	0.00236	CcSEcCtD
Bimatoprost—Mediastinal disorder—Lisinopril—systemic scleroderma	0.00212	0.00235	CcSEcCtD
Bimatoprost—Palpitations—Leflunomide—systemic scleroderma	0.00211	0.00233	CcSEcCtD
Bimatoprost—Dyspnoea—Captopril—systemic scleroderma	0.0021	0.00233	CcSEcCtD
Bimatoprost—Bladder pain—Methotrexate—systemic scleroderma	0.0021	0.00233	CcSEcCtD
Bimatoprost—Somnolence—Captopril—systemic scleroderma	0.0021	0.00232	CcSEcCtD
Bimatoprost—Cough—Leflunomide—systemic scleroderma	0.00208	0.0023	CcSEcCtD
Bimatoprost—Dyspepsia—Captopril—systemic scleroderma	0.00208	0.0023	CcSEcCtD
Bimatoprost—Rhinitis—Mycophenolate mofetil—systemic scleroderma	0.00207	0.00229	CcSEcCtD
Bimatoprost—Dizziness—Pentoxifylline—systemic scleroderma	0.00206	0.00228	CcSEcCtD
Bimatoprost—Hypertension—Leflunomide—systemic scleroderma	0.00206	0.00228	CcSEcCtD
Bimatoprost—Erythema—Lisinopril—systemic scleroderma	0.00205	0.00227	CcSEcCtD
Bimatoprost—Infection—Azathioprine—systemic scleroderma	0.00205	0.00226	CcSEcCtD
Bimatoprost—Pharyngitis—Mycophenolate mofetil—systemic scleroderma	0.00205	0.00226	CcSEcCtD
Bimatoprost—Vertigo—Mycophenolic acid—systemic scleroderma	0.00204	0.00226	CcSEcCtD
Bimatoprost—Oedema peripheral—Mycophenolate mofetil—systemic scleroderma	0.00203	0.00225	CcSEcCtD
Bimatoprost—Chest pain—Leflunomide—systemic scleroderma	0.00203	0.00225	CcSEcCtD
Bimatoprost—Connective tissue disorder—Mycophenolate mofetil—systemic scleroderma	0.00203	0.00224	CcSEcCtD
Bimatoprost—Anxiety—Leflunomide—systemic scleroderma	0.00202	0.00224	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.00202	0.00223	CcSEcCtD
Bimatoprost—Tension—Lisinopril—systemic scleroderma	0.00201	0.00222	CcSEcCtD
Bimatoprost—Palpitations—Mycophenolic acid—systemic scleroderma	0.00201	0.00222	CcSEcCtD
Bimatoprost—Skin disorder—Azathioprine—systemic scleroderma	0.002	0.00221	CcSEcCtD
Bimatoprost—Nervousness—Lisinopril—systemic scleroderma	0.00199	0.0022	CcSEcCtD
Bimatoprost—Visual impairment—Mycophenolate mofetil—systemic scleroderma	0.00199	0.0022	CcSEcCtD
Bimatoprost—Dry mouth—Leflunomide—systemic scleroderma	0.00198	0.0022	CcSEcCtD
Bimatoprost—Cough—Mycophenolic acid—systemic scleroderma	0.00198	0.0022	CcSEcCtD
Bimatoprost—Rash—Pentoxifylline—systemic scleroderma	0.00196	0.00217	CcSEcCtD
Bimatoprost—Hypertension—Mycophenolic acid—systemic scleroderma	0.00196	0.00217	CcSEcCtD
Bimatoprost—Dermatitis—Pentoxifylline—systemic scleroderma	0.00196	0.00217	CcSEcCtD
Bimatoprost—Headache—Pentoxifylline—systemic scleroderma	0.00195	0.00216	CcSEcCtD
Bimatoprost—Chest pain—Mycophenolic acid—systemic scleroderma	0.00194	0.00214	CcSEcCtD
Bimatoprost—Infection—Leflunomide—systemic scleroderma	0.00193	0.00214	CcSEcCtD
Bimatoprost—Vision blurred—Lisinopril—systemic scleroderma	0.00193	0.00214	CcSEcCtD
Bimatoprost—Anxiety—Mycophenolic acid—systemic scleroderma	0.00193	0.00213	CcSEcCtD
Bimatoprost—Asthenia—Mometasone—systemic scleroderma	0.00193	0.00213	CcSEcCtD
Bimatoprost—Eye disorder—Mycophenolate mofetil—systemic scleroderma	0.00193	0.00213	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.00192	0.00213	CcSEcCtD
Bimatoprost—Nervous system disorder—Leflunomide—systemic scleroderma	0.00191	0.00211	CcSEcCtD
Bimatoprost—Pruritus—Mometasone—systemic scleroderma	0.0019	0.0021	CcSEcCtD
Bimatoprost—Dry mouth—Mycophenolic acid—systemic scleroderma	0.00189	0.00209	CcSEcCtD
Bimatoprost—Skin disorder—Leflunomide—systemic scleroderma	0.00189	0.00209	CcSEcCtD
Bimatoprost—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.00187	0.00207	CcSEcCtD
Bimatoprost—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00186	0.00206	CcSEcCtD
Bimatoprost—Dry skin—Prednisone—systemic scleroderma	0.00185	0.00205	CcSEcCtD
Bimatoprost—Nausea—Pentoxifylline—systemic scleroderma	0.00185	0.00205	CcSEcCtD
Bimatoprost—Infection—Mycophenolic acid—systemic scleroderma	0.00184	0.00204	CcSEcCtD
Bimatoprost—Vertigo—Lisinopril—systemic scleroderma	0.00184	0.00204	CcSEcCtD
Bimatoprost—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.00182	0.00201	CcSEcCtD
Bimatoprost—Palpitations—Lisinopril—systemic scleroderma	0.00181	0.002	CcSEcCtD
Bimatoprost—Skin disorder—Mycophenolic acid—systemic scleroderma	0.0018	0.00199	CcSEcCtD
Bimatoprost—Cough—Lisinopril—systemic scleroderma	0.00179	0.00198	CcSEcCtD
Bimatoprost—Visual disturbance—Methotrexate—systemic scleroderma	0.00178	0.00197	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00178	0.00197	CcSEcCtD
Bimatoprost—Tension—Mycophenolate mofetil—systemic scleroderma	0.00176	0.00195	CcSEcCtD
Bimatoprost—Insomnia—Leflunomide—systemic scleroderma	0.00176	0.00195	CcSEcCtD
Bimatoprost—Chest pain—Lisinopril—systemic scleroderma	0.00174	0.00193	CcSEcCtD
Bimatoprost—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.00174	0.00193	CcSEcCtD
Bimatoprost—Anxiety—Lisinopril—systemic scleroderma	0.00174	0.00192	CcSEcCtD
Bimatoprost—Dyspnoea—Leflunomide—systemic scleroderma	0.00173	0.00192	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.00173	0.00192	CcSEcCtD
Bimatoprost—Dyspepsia—Leflunomide—systemic scleroderma	0.00171	0.00189	CcSEcCtD
Bimatoprost—Dry mouth—Lisinopril—systemic scleroderma	0.00171	0.00189	CcSEcCtD
Bimatoprost—Rash—Mometasone—systemic scleroderma	0.00169	0.00187	CcSEcCtD
Bimatoprost—Asthenia—Captopril—systemic scleroderma	0.00169	0.00187	CcSEcCtD
Bimatoprost—Dermatitis—Mometasone—systemic scleroderma	0.00169	0.00187	CcSEcCtD
Bimatoprost—Headache—Mometasone—systemic scleroderma	0.00168	0.00186	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00168	0.00186	CcSEcCtD
Bimatoprost—Insomnia—Mycophenolic acid—systemic scleroderma	0.00168	0.00186	CcSEcCtD
Bimatoprost—Pruritus—Captopril—systemic scleroderma	0.00167	0.00185	CcSEcCtD
Bimatoprost—Pain—Leflunomide—systemic scleroderma	0.00166	0.00184	CcSEcCtD
Bimatoprost—Infection—Lisinopril—systemic scleroderma	0.00166	0.00184	CcSEcCtD
Bimatoprost—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00165	0.00183	CcSEcCtD
Bimatoprost—Somnolence—Mycophenolic acid—systemic scleroderma	0.00165	0.00183	CcSEcCtD
Bimatoprost—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00163	0.00181	CcSEcCtD
Bimatoprost—Skin disorder—Lisinopril—systemic scleroderma	0.00162	0.0018	CcSEcCtD
Bimatoprost—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00161	0.00178	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.0016	0.00177	CcSEcCtD
Bimatoprost—Nausea—Mometasone—systemic scleroderma	0.0016	0.00177	CcSEcCtD
Bimatoprost—Pain—Mycophenolic acid—systemic scleroderma	0.00159	0.00176	CcSEcCtD
Bimatoprost—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00159	0.00175	CcSEcCtD
Bimatoprost—Cough—Mycophenolate mofetil—systemic scleroderma	0.00157	0.00173	CcSEcCtD
Bimatoprost—Dizziness—Captopril—systemic scleroderma	0.00156	0.00173	CcSEcCtD
Bimatoprost—Liver function test abnormal—Methotrexate—systemic scleroderma	0.00156	0.00172	CcSEcCtD
Bimatoprost—Depression—Prednisone—systemic scleroderma	0.00155	0.00172	CcSEcCtD
Bimatoprost—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.00155	0.00171	CcSEcCtD
Bimatoprost—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.00153	0.00169	CcSEcCtD
Bimatoprost—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.00152	0.00168	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.00152	0.00168	CcSEcCtD
Bimatoprost—Insomnia—Lisinopril—systemic scleroderma	0.00151	0.00167	CcSEcCtD
Bimatoprost—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.00149	0.00165	CcSEcCtD
Bimatoprost—Dyspnoea—Lisinopril—systemic scleroderma	0.00149	0.00165	CcSEcCtD
Bimatoprost—Rash—Captopril—systemic scleroderma	0.00149	0.00165	CcSEcCtD
Bimatoprost—Dermatitis—Captopril—systemic scleroderma	0.00149	0.00164	CcSEcCtD
Bimatoprost—Somnolence—Lisinopril—systemic scleroderma	0.00149	0.00164	CcSEcCtD
Bimatoprost—Headache—Captopril—systemic scleroderma	0.00148	0.00164	CcSEcCtD
Bimatoprost—Dyspepsia—Lisinopril—systemic scleroderma	0.00147	0.00163	CcSEcCtD
Bimatoprost—Asthma—Methotrexate—systemic scleroderma	0.00146	0.00161	CcSEcCtD
Bimatoprost—Infection—Mycophenolate mofetil—systemic scleroderma	0.00145	0.00161	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00144	0.0016	CcSEcCtD
Bimatoprost—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00144	0.00159	CcSEcCtD
Bimatoprost—Pain—Lisinopril—systemic scleroderma	0.00143	0.00158	CcSEcCtD
Bimatoprost—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00142	0.00157	CcSEcCtD
Bimatoprost—Nausea—Captopril—systemic scleroderma	0.0014	0.00155	CcSEcCtD
Bimatoprost—Asthenia—Leflunomide—systemic scleroderma	0.0014	0.00154	CcSEcCtD
Bimatoprost—Pruritus—Leflunomide—systemic scleroderma	0.00138	0.00152	CcSEcCtD
Bimatoprost—Connective tissue disorder—Prednisone—systemic scleroderma	0.00137	0.00152	CcSEcCtD
Bimatoprost—Dizziness—Azathioprine—systemic scleroderma	0.00136	0.00151	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.00136	0.0015	CcSEcCtD
Bimatoprost—Asthenia—Mycophenolic acid—systemic scleroderma	0.00133	0.00147	CcSEcCtD
Bimatoprost—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00132	0.00147	CcSEcCtD
Bimatoprost—Pruritus—Mycophenolic acid—systemic scleroderma	0.00131	0.00145	CcSEcCtD
Bimatoprost—Eye disorder—Prednisone—systemic scleroderma	0.00131	0.00144	CcSEcCtD
Bimatoprost—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00131	0.00144	CcSEcCtD
Bimatoprost—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.0013	0.00144	CcSEcCtD
Bimatoprost—Rash—Azathioprine—systemic scleroderma	0.0013	0.00144	CcSEcCtD
Bimatoprost—Dermatitis—Azathioprine—systemic scleroderma	0.0013	0.00144	CcSEcCtD
Bimatoprost—Depression—Methotrexate—systemic scleroderma	0.0013	0.00144	CcSEcCtD
Bimatoprost—Headache—Azathioprine—systemic scleroderma	0.00129	0.00143	CcSEcCtD
Bimatoprost—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.00129	0.00143	CcSEcCtD
Bimatoprost—Dizziness—Leflunomide—systemic scleroderma	0.00129	0.00142	CcSEcCtD
Bimatoprost—Angiopathy—Prednisone—systemic scleroderma	0.00127	0.0014	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00126	0.0014	CcSEcCtD
Bimatoprost—Pain—Mycophenolate mofetil—systemic scleroderma	0.00125	0.00139	CcSEcCtD
Bimatoprost—Dizziness—Mycophenolic acid—systemic scleroderma	0.00123	0.00136	CcSEcCtD
Bimatoprost—Rash—Leflunomide—systemic scleroderma	0.00123	0.00136	CcSEcCtD
Bimatoprost—Dermatitis—Leflunomide—systemic scleroderma	0.00123	0.00136	CcSEcCtD
Bimatoprost—Nausea—Azathioprine—systemic scleroderma	0.00122	0.00135	CcSEcCtD
Bimatoprost—Headache—Leflunomide—systemic scleroderma	0.00122	0.00135	CcSEcCtD
Bimatoprost—Erythema—Prednisone—systemic scleroderma	0.00122	0.00135	CcSEcCtD
Bimatoprost—Asthenia—Lisinopril—systemic scleroderma	0.0012	0.00133	CcSEcCtD
Bimatoprost—Pruritus—Lisinopril—systemic scleroderma	0.00118	0.00131	CcSEcCtD
Bimatoprost—Rash—Mycophenolic acid—systemic scleroderma	0.00117	0.00129	CcSEcCtD
Bimatoprost—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00117	0.00129	CcSEcCtD
Bimatoprost—Headache—Mycophenolic acid—systemic scleroderma	0.00116	0.00129	CcSEcCtD
Bimatoprost—Pharyngitis—Methotrexate—systemic scleroderma	0.00116	0.00128	CcSEcCtD
Bimatoprost—Nausea—Leflunomide—systemic scleroderma	0.00116	0.00128	CcSEcCtD
Bimatoprost—Vision blurred—Prednisone—systemic scleroderma	0.00115	0.00127	CcSEcCtD
Bimatoprost—Visual impairment—Methotrexate—systemic scleroderma	0.00113	0.00125	CcSEcCtD
Bimatoprost—Dizziness—Lisinopril—systemic scleroderma	0.00111	0.00122	CcSEcCtD
Bimatoprost—Nausea—Mycophenolic acid—systemic scleroderma	0.0011	0.00122	CcSEcCtD
Bimatoprost—Vertigo—Prednisone—systemic scleroderma	0.00109	0.00121	CcSEcCtD
Bimatoprost—Eye disorder—Methotrexate—systemic scleroderma	0.00109	0.00121	CcSEcCtD
Bimatoprost—Angiopathy—Methotrexate—systemic scleroderma	0.00106	0.00117	CcSEcCtD
Bimatoprost—Rash—Lisinopril—systemic scleroderma	0.00105	0.00117	CcSEcCtD
Bimatoprost—Dermatitis—Lisinopril—systemic scleroderma	0.00105	0.00116	CcSEcCtD
Bimatoprost—Mediastinal disorder—Methotrexate—systemic scleroderma	0.00105	0.00116	CcSEcCtD
Bimatoprost—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00105	0.00116	CcSEcCtD
Bimatoprost—Hypertension—Prednisone—systemic scleroderma	0.00105	0.00116	CcSEcCtD
Bimatoprost—Headache—Lisinopril—systemic scleroderma	0.00105	0.00116	CcSEcCtD
Bimatoprost—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00104	0.00115	CcSEcCtD
Bimatoprost—Anxiety—Prednisone—systemic scleroderma	0.00103	0.00114	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.00103	0.00114	CcSEcCtD
Bimatoprost—Erythema—Methotrexate—systemic scleroderma	0.00102	0.00112	CcSEcCtD
Bimatoprost—Nausea—Lisinopril—systemic scleroderma	0.000993	0.0011	CcSEcCtD
Bimatoprost—Infection—Prednisone—systemic scleroderma	0.000986	0.00109	CcSEcCtD
Bimatoprost—Nervous system disorder—Prednisone—systemic scleroderma	0.000973	0.00108	CcSEcCtD
Bimatoprost—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000968	0.00107	CcSEcCtD
Bimatoprost—Skin disorder—Prednisone—systemic scleroderma	0.000964	0.00107	CcSEcCtD
Bimatoprost—Vision blurred—Methotrexate—systemic scleroderma	0.000958	0.00106	CcSEcCtD
Bimatoprost—Rash—Mycophenolate mofetil—systemic scleroderma	0.000923	0.00102	CcSEcCtD
Bimatoprost—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000922	0.00102	CcSEcCtD
Bimatoprost—Headache—Mycophenolate mofetil—systemic scleroderma	0.000917	0.00102	CcSEcCtD
Bimatoprost—Vertigo—Methotrexate—systemic scleroderma	0.000913	0.00101	CcSEcCtD
Bimatoprost—Insomnia—Prednisone—systemic scleroderma	0.000898	0.000993	CcSEcCtD
Bimatoprost—Cough—Methotrexate—systemic scleroderma	0.000887	0.000981	CcSEcCtD
Bimatoprost—Dyspepsia—Prednisone—systemic scleroderma	0.000874	0.000967	CcSEcCtD
Bimatoprost—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00087	0.000962	CcSEcCtD
Bimatoprost—Chest pain—Methotrexate—systemic scleroderma	0.000865	0.000958	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000859	0.000951	CcSEcCtD
Bimatoprost—Infection—Methotrexate—systemic scleroderma	0.000824	0.000912	CcSEcCtD
Bimatoprost—Nervous system disorder—Methotrexate—systemic scleroderma	0.000814	0.0009	CcSEcCtD
Bimatoprost—Skin disorder—Methotrexate—systemic scleroderma	0.000806	0.000892	CcSEcCtD
Bimatoprost—Insomnia—Methotrexate—systemic scleroderma	0.00075	0.00083	CcSEcCtD
Bimatoprost—Dyspnoea—Methotrexate—systemic scleroderma	0.00074	0.000818	CcSEcCtD
Bimatoprost—Somnolence—Methotrexate—systemic scleroderma	0.000737	0.000816	CcSEcCtD
Bimatoprost—Dyspepsia—Methotrexate—systemic scleroderma	0.00073	0.000808	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000716	0.000792	CcSEcCtD
Bimatoprost—Asthenia—Prednisone—systemic scleroderma	0.000712	0.000788	CcSEcCtD
Bimatoprost—Pain—Methotrexate—systemic scleroderma	0.000709	0.000785	CcSEcCtD
Bimatoprost—Pruritus—Prednisone—systemic scleroderma	0.000702	0.000777	CcSEcCtD
Bimatoprost—Dizziness—Prednisone—systemic scleroderma	0.000656	0.000726	CcSEcCtD
Bimatoprost—Rash—Prednisone—systemic scleroderma	0.000626	0.000693	CcSEcCtD
Bimatoprost—Dermatitis—Prednisone—systemic scleroderma	0.000625	0.000692	CcSEcCtD
Bimatoprost—Headache—Prednisone—systemic scleroderma	0.000622	0.000688	CcSEcCtD
Bimatoprost—Asthenia—Methotrexate—systemic scleroderma	0.000595	0.000659	CcSEcCtD
Bimatoprost—Nausea—Prednisone—systemic scleroderma	0.00059	0.000652	CcSEcCtD
Bimatoprost—Pruritus—Methotrexate—systemic scleroderma	0.000587	0.000649	CcSEcCtD
Bimatoprost—Dizziness—Methotrexate—systemic scleroderma	0.000549	0.000607	CcSEcCtD
Bimatoprost—Rash—Methotrexate—systemic scleroderma	0.000523	0.000579	CcSEcCtD
Bimatoprost—Dermatitis—Methotrexate—systemic scleroderma	0.000523	0.000578	CcSEcCtD
Bimatoprost—Headache—Methotrexate—systemic scleroderma	0.00052	0.000575	CcSEcCtD
Bimatoprost—Nausea—Methotrexate—systemic scleroderma	0.000493	0.000545	CcSEcCtD
